Evidence map›Paper›PMID 25016020›Full record

ArticleThe Journal of biological chemistry2014

Male fertility defect associated with disrupted BRCA1-PALB2 interaction in mice.

Srilatha Simhadri, Shaun Peterson, Dharm S Patel, Yanying Huo, Hong Cai, Christian Bowman-Colin, Shoreh Miller, Thomas Ludwig, Shridar Ganesan, Mantu Bhaumik and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 77 citations in OpenAlex.

  1. Double jeopardy: howFrontiers in cell and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. BRCA1 safeguards genome integrity by activating chromosome asynapsis checkpoint to eliminate recombination-defective oocytes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Review
  7. BRCA Mutations and Fertility Preservation.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Cell genomics · 2023
    Article
  11. Review
  12. Human APOBEC3B promotes tumor heterogeneitybioRxiv : the preprint server for biology · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Srilatha SimhadriFrom the Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, the Departments of Radiation Oncology.
Shaun Petersonthe Developmental Biology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.
Dharm S Patelthe Department of Molecular Biology and Biochemistry, School of Arts and Sciences, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854.
Yanying HuoFrom the Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, the Departments of Radiation Oncology.
Hong CaiFrom the Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, the Departments of Radiation Oncology.
Christian Bowman-Colinthe Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, and.
Shoreh MillerPediatrics, and.
Thomas Ludwigthe Department of Molecular and Cellular Biochemistry, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Shridar GanesanFrom the Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey 08901.
Mantu BhaumikFrom the Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, Pediatrics, and.
Samuel F Buntingthe Department of Molecular Biology and Biochemistry, School of Arts and Sciences, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854.
Maria Jasinthe Developmental Biology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.
Bing XiaFrom the Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, the Departments of Radiation Oncology, xiabi@cinj.rutgers.edu.
Rutgers Cancer Institute of New JerseyRutgers, The State University of New Jersey · USMemorial Sloan Kettering Cancer Center · USDana-Farber Cancer Institute · USThe Ohio State University Wexner Medical Center · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Shridar Ganesan · 1997 to 2026
$94.5M
UMDNJ TRAINING GRANT IN BIOTECHNOLOGYT32GM008339 · NIGMS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI YARMUSH, MARTIN L · 1989 to 2019
$6.1M
Role of PALB2 in the DNA Damage Response and Cancer SuppressionR01CA138804 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI XIA, BING · 2009 to 2024
$5.5M
Role of Spo11 and recombination in mouse meiosisR01GM105421 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI JASIN, MARIA, KEENEY, SCOTT · 2013 to 2016
$2.4M
53BP1-Mediated Regulation of DNA Repair and ChemoresistanceR01CA169182 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI GANESAN, SHRIDAR · 2012 to 2016
$1.6M
Targeted therapies to correct genomic instability in Brca1-deficient cells.R00CA160574 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI BUNTING, SAMUEL · 2012 to 2014
$723k
NCI NIH HHS P30 CA072720NCI NIH HHS R00 CA160574NCI NIH HHS R00CA160574NCI NIH HHS R01 CA138804NCI NIH HHS R01CA138804NCI NIH HHS R01 CA169182NIGMS NIH HHS R01 GM105421NIGMS NIH HHS R01GM105421NIGMS NIH HHS T32 GM008339
6 · The paper itself

Abstract

PALB2 links BRCA1 and BRCA2 in homologous recombinational repair of DNA double strand breaks (DSBs). Mono-allelic mutations in PALB2 increase the risk of breast, pancreatic, and other cancers, and biallelic mutations cause Fanconi anemia (FA). Like Brca1 and Brca2, systemic knock-out of Palb2 in mice results in embryonic lethality. In this study, we generated a hypomorphic Palb2 allele expressing a mutant PALB2 protein unable to bind BRCA1. Consistent with an FA-like phenotype, cells from the mutant mice showed hypersensitivity and chromosomal breakage when treated with mitomycin C, a DNA interstrand crosslinker. Moreover, mutant males showed reduced fertility due to impaired meiosis and increased apoptosis in germ cells. Interestingly, mutant meiocytes showed a significant defect in sex chromosome synapsis, which likely contributed to the germ cell loss and fertility defect. Our results underscore the in vivo importance of the PALB2-BRCA1 complex formation in DSB repair and male meiosis.

Indexed as

Amino Acid SequenceAnimalsBRCA1 ProteinDNA DamageDNA RepairFanconi Anemia Complementation Group N ProteinHomologous RecombinationHumansInfertility, MaleIn Situ Nick-End LabelingMaleMiceMolecular Sequence DataSequence Homology, Amino AcidTumor Suppressor ProteinsBRCA1 ProteinFanconi Anemia Complementation Group N ProteinPalb2 protein, mouseTumor Suppressor ProteinsBRCA1BRCA2DNA Damage ResponseFANCNFanconi AnemiaHomologous RecombinationMale InfertilityMeiosisPALB2Spermatogenesis

Identifiers

PMID25016020
PMCPMC4148885
OpenAlexW2064446297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.